IKZF1 and neoplasm: In the neoadjuvant chemotherapy study of muscle-invasive bladder cancer with high tumor mutation burden, it was found that chromosome 7p12 amplification (including IKZF1) can predict that patients will not respond to treatment with a specificity of 100%, suggesting that IKZF1 may be involved in tumor cell DNA damage repair.